|
2023
|
Invention
|
Methods of treating neutorpenia using g-csf protein complex.
This disclosure provides a method o... |
|
|
Invention
|
Novel methods of treating neutorpenia using g-csf protein complex.
This disclosure provides a me... |
|
|
Invention
|
Methods for promoting anti-tumor immune response in a subject in need thereof using encapsulated ... |
|
2022
|
Invention
|
Inhibitors of mutant family tyrosine-kinases.
An epidermal growth factor receptor (EGFR) family ... |
|
|
Invention
|
Treatment of non-small cell lung cancer with poziotinib. A method of treating NSCLC in a subject ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of cancer and related symptoms; phar... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention
of cancer and related symptoms; pha... |
|
|
P/S
|
Referral services in the field of treatment for cancer, chemotherapy and pharmaceutical products ... |
|
|
P/S
|
Pharmaceuticals for the treatment of cancer; pharmaceuticals for oncological treatment. |
|
|
P/S
|
Pharmaceuticals for the treatment of cancer; pharmaceuticals
for oncological treatment. |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of cancer and related symptoms; Phar... |
|
2021
|
Invention
|
Treatment of malignant solid tumors. A method of treating solid tumors in a subject is disclosed ... |
|
|
Invention
|
Novel heterocyclic compounds. A novel class of compounds as KRas G12C inhibitors. Also disclosed ... |
|
|
Invention
|
Novel bicyclic compounds. A novel class of compounds as KRas G12C inhibitors. Also disclosed are ... |
|
|
P/S
|
Pharmaceuticals for the treatment of cancer; pharmaceuticals for oncological treatment |
|
|
Invention
|
Novel methods of treating neutropenia using g-csf protein complex. This disclosure provides a met... |
|
|
Invention
|
Methods of treating chemotherapy induced neutropenia using fixed doses of eflapegrastim. This dis... |
|
|
Invention
|
Methods of treating chemotherapy induced neutropenia using fixed doses of g-csf protein complex. ... |
|
2020
|
Invention
|
Methods of treatment using g-csf protein complex.
This disclosure provides a method of preventin... |
|
|
Invention
|
Methods of treatment using g-csf protein complex. This disclosure provides a method of preventing... |
|
|
Invention
|
Poziotinib combination with vegfr2 inhibitors and methods of use thereof.
A drug combination con... |
|
|
Invention
|
Poziotinib combination with vegfr2 inhibitors and methods of use thereof. A drug combination cont... |
|
|
Invention
|
Methods of treating neutorpenia using g-csf protein complex. This disclosure provides a method of... |
|
2019
|
P/S
|
Pharmaceutical preparations and substances for use in oncology; Pharmaceutical products for the t... |
|
|
Invention
|
Novel quinazoline egfr inhibitors.
This document discloses a novel class of quinazoline EGFR inh... |
|
|
Invention
|
Novel quinazoline egfr inhibitors. This document discloses a novel class of quinazolirie EGFR inh... |
|
|
Invention
|
Novel quinazoline egfr inhibitors. This document discloses a novel class of quinazoline EGFR inhi... |
|
|
Invention
|
Crystalline forms of a quinazoline compound and its hydrochloride salts. This patent document rel... |
|
|
Invention
|
Kits and methods for treating cancers.
A kit containing a crystalline form of a quinazoline comp... |
|
|
Invention
|
Kits and methods for treating cancers. A kit containing a crystalline form of a quinazoline compo... |
|
|
Invention
|
Poziotinib combinations with an anti-her1, her2 or her4 antibody and methods of use thereof.
Pro... |
|
|
Invention
|
Combination of poziotinib with cytotoxic agent and/or other molecularly targeted agent and use th... |
|
|
Invention
|
Poziotinib combinations with an anti-her1, her2 or her4 antibody and methods of use thereof. Prov... |
|
2018
|
Invention
|
Inhibitors of mutant egfr family tyrosine-kinases. An epidermal growth factor receptor (EGFR) fam... |
|
|
Invention
|
Treatment of primary and metastatic carcinoma.
Disclosed are methods of treating a chemotherapy-... |
|
2017
|
P/S
|
Pharmaceutical preparations for the prevention and treatment
of cancer and related symptoms; pha... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment
of cancer and related symptoms. |
|
2016
|
Invention
|
A ready-to-use formulation for vincristine sulfate liposome injection. Disclosed herein are vario... |
|
|
Invention
|
Combination therapy using belinostat and pralatrexate to treat lymphoma. The present invention re... |
|
|
Invention
|
Treatment of primary and metastatic carcinoma. B) receptor agonist and a chemotherapeutic agent t... |
|
2015
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
2014
|
P/S
|
Pharmaceutical preparations namely those for the treatment, prevention and diagnosis of bacterial... |
|
|
Invention
|
Rare earth metal compounds, methods of making, and methods of using the same.
Rare earth metal c... |
|
|
Invention
|
Formulations of vitamin k analogs for topical use.
The present invention provides topical formul... |
|
|
Invention
|
Bladder cancer treatment and methods.
Therapeutic compositions comprising an indoloquinone compo... |
|
2013
|
P/S
|
Pharmaceutical preparations, namely those for the treatment,
prevention, and diagnosis of bacter... |
|
|
Invention
|
Thioxanthone-based autophagy inhibitor therapies to treat cancer. The present specification provi... |
|
2008
|
P/S
|
CONSULTATION IN THE FIELD OF THE PURCHASE OF PHARMACEUTICALS |
|
2006
|
P/S
|
Pharmaceutical preparations, namely, those for the treatment, prevention, and diagnosis of [ bact... |
|
2004
|
P/S
|
Pharmaceutical preparation for the treatment of cancer. |
